<DOC>
	<DOC>NCT00474487</DOC>
	<brief_summary>This study will evaluate the safety and immune response of Novartis Meningococcal ACWY conjugate vaccine in healthy adolescents and adults.</brief_summary>
	<brief_title>A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis, Meningococcal</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>individuals who are 1965 years of age inclusive and who, after the nature of the study has been explained have provided written informed consent individuals who are available for all visits and telephone calls scheduled for the study; individuals who are in good health individuals with a previous or suspected disease caused by N. meningitidis individuals with previous immunization with a meningococcal vaccine or vaccine containing meningococcal antigen(s) individuals with previous or suspected disease caused by N. meningitidis individuals with any serious acute, chronic or progressive disease individuals who are pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Meningococcal</keyword>
	<keyword>meningitis</keyword>
	<keyword>vaccine</keyword>
	<keyword>adolescents</keyword>
	<keyword>adults</keyword>
</DOC>